Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Applied Genetic Technologies Corp    AGTC

APPLIED GENETIC TECHNOLOGIES CORP

(AGTC)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/15/2019 07/16/2019 07/17/2019 07/18/2019 07/19/2019 Date
3.8(c) 3.79(c) 3.88(c) 3.88(c) 3.88(c) Last
24 424 185 851 68 482 52 362 196 082 Volume
+3.54% -0.26% +2.37% 0.00% 0.00% Change
More quotes
Financials (USD)
Sales 2019 44,0 M
EBIT 2019 -4,19 M
Net income 2019 -2,43 M
Debt 2019 -
Yield 2019 -
Sales 2020 10,3 M
EBIT 2020 -54,5 M
Net income 2020 -53,4 M
Debt 2020 -
Yield 2020 -
P/E ratio 2019 -29,8x
P/E ratio 2020 -1,76x
Capi. / Sales2019 1,60x
Capi. / Sales2020 6,88x
Capitalization 70,5 M
More Financials
Company
Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. The Company develops gene therapy products designed to manage the lives of patients with severe diseases in ophthalmology. As of March 31, 2016, its product candidates included treatments for X-linked retinoschisis... 
More about the company
Surperformance© ratings of Applied Genetic Technologi
Trading Rating : Investor Rating :
More Ratings
Latest news on APPLIED GENETIC TECHNOLOGI
06/25APPLIED GENETIC TECHNOLOGIES CORP : Change in Directors or Principal Officers, R..
AQ
06/25AGTC Announces New Leadership Appointments
GL
06/18AGTC to Present at BMO Capital Markets 2019 Prescriptions for Success Healthc..
GL
05/07APPLIED GENETIC TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL..
AQ
05/07APPLIED GENETIC TECHNOLOGIES : Fiscal 3Q Earnings Snapshot
AQ
05/07APPLIED GENETIC TECHNOLOGIES CORP : Results of Operations and Financial Conditio..
AQ
05/07AGTC Announces Financial Results and Business Update for the Quarter Ended Ma..
GL
04/30AGTC to Host Third Quarter Financial Results Conference Call and Webcast on M..
GL
04/08APPLIED GENETIC TECHNOLOGIES : AGTC Announces Reaching Enrollment Milestones in ..
AQ
03/04Biogen Expands Into Gene Therapy for Eye Disease
DJ
More news
Analyst Recommendations on APPLIED GENETIC TECHNOLOGI
More recommendations
Sector news : Bio Therapeutic Drugs
07/19Gilead Licenses Respiratory, Herpes Antiviral Research Programs From Novartis
DJ
07/17GILEAD SCIENCES : Chief Scientific Officer John McHutchison to Leave
DJ
07/16As steep patent cliff looms, Shionogi moves to develop its own U.S. sales sta..
RE
07/16GSK's two-drug HIV Dovato treatment meets main goal in study
RE
07/15Gilead invests $5 billion to deepen ties with biotech Galapagos
RE
More sector news : Bio Therapeutic Drugs
Chart APPLIED GENETIC TECHNOLOGIES CORP
Duration : Period :
Applied Genetic Technologies Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends APPLIED GENETIC TECHNOLOGI
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 9,60  $
Last Close Price 3,88  $
Spread / Highest target 287%
Spread / Average Target 147%
Spread / Lowest Target 28,9%
EPS Revisions
Managers
NameTitle
Susan B. Washer President, Chief Executive Officer & Director
Scott E. Koenig Chairman
William A. Sullivan CFO & Principal Accounting Officer
Mark S. Shearman Chief Scientific Officer & Vice President
Matthew Feinsod Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
APPLIED GENETIC TECHNOLOGIES CORP55.82%71
GILEAD SCIENCES3.98%82 702
VERTEX PHARMACEUTICALS7.47%44 598
REGENERON PHARMACEUTICALS-20.18%32 544
GENMAB14.94%11 908
SAREPTA THERAPEUTICS INC36.77%11 068